These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 7074655

  • 1. Role of radiation therapy in the treatment of Hodgkin's disease.
    Hellman S, Mauch P.
    Cancer Treat Rep; 1982 Apr; 66(4):915-23. PubMed ID: 7074655
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Influence of mediastinal adenopathy on site and frequency of relapse in patients with Hodgkin's disease.
    Mauch P, Gorshein D, Cunningham J, Hellman S.
    Cancer Treat Rep; 1982 Apr; 66(4):809-17. PubMed ID: 7074652
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of stage IIIA Hodgkin's disease.
    Neely SM, Golomb HM.
    Cancer Treat Rep; 1982 Apr; 66(4):827-34. PubMed ID: 7074654
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Petera J, Macharová H, Pohanková R, Malír A, Coupek P, Konecný M, Patera J, Pecina J, Drbal J, Koukalová H, Vásová I.
    Neoplasma; 2000 Apr; 47(2):129-32. PubMed ID: 10985481
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.
    Campbell BA, Voss N, Pickles T, Morris J, Gascoyne RD, Savage KJ, Connors JM.
    J Clin Oncol; 2008 Nov 10; 26(32):5170-4. PubMed ID: 18838714
    [Abstract] [Full Text] [Related]

  • 12. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Muwakkit S, Geara F, Nabbout B, Farah RA, Shabb NS, Hajjar T, Khogali M.
    Radiat Oncol Investig; 1999 Nov 10; 7(6):365-73. PubMed ID: 10644060
    [Abstract] [Full Text] [Related]

  • 13. Hodgkin's disease in a community oncology center: ten years' experience.
    Beck TM, Montgomery P, Smith CE.
    West J Med; 1982 May 10; 136(5):384-9. PubMed ID: 7101905
    [Abstract] [Full Text] [Related]

  • 14. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
    Koontz BF, Kirkpatrick JP, Clough RW, Prosnitz RG, Gockerman JP, Moore JO, Prosnitz LR.
    J Clin Oncol; 2006 Feb 01; 24(4):605-11. PubMed ID: 16446333
    [Abstract] [Full Text] [Related]

  • 15. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
    Meyer RM, Gospodarowicz MK, Connors JM, Pearcey RG, Bezjak A, Wells WA, Burns BF, Winter JN, Horning SJ, Dar AR, Djurfeldt MS, Ding K, Shepherd LE, National Cancer Institute of Canada Clinical Trials Group, Eastern Cooperative Oncology Group.
    J Clin Oncol; 2005 Jul 20; 23(21):4634-42. PubMed ID: 15837968
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
    Wang WH, Li YX, Song YW, Jin J, Liu YP, Wang SL, Zhou LQ, Liu XF, Yu ZH, Han JZ.
    Zhonghua Zhong Liu Za Zhi; 2006 Mar 20; 28(3):218-21. PubMed ID: 16875611
    [Abstract] [Full Text] [Related]

  • 19. Site of relapse after chemotherapy alone for stage I and II Hodgkin's disease.
    Shahidi M, Kamangari N, Ashley S, Cunningham D, Horwich A.
    Radiother Oncol; 2006 Jan 20; 78(1):1-5. PubMed ID: 16309770
    [Abstract] [Full Text] [Related]

  • 20. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
    Hudson MM, Krasin M, Link MP, Donaldson SS, Billups C, Merchant TE, Kun L, Billet AL, Kaste S, Tarbell NJ, Howard S, Friedmann AM, Hurwitz CA, Young JA, Marcus KC, Rai S, Cowan T, Weinstein HJ.
    J Clin Oncol; 2004 Nov 15; 22(22):4541-50. PubMed ID: 15542805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.